C Cube Lab
- Biotech or pharma, therapeutic R&D
- Financial, legal, consulting
At this event, we represent EHL Bio primarily from a business development perspective.
EHL Bio Co., Ltd. is a leading Korean biotechnology company specializing in stem cell research and regenerative medicine, with a particular focus on the development of KD Stem (KDSTEM), an innovative urine-derived stem cell therapy for chronic kidney disease.
KD Stem is designed as a cell therapy product for patients with chronic kidney disease, utilizing stem cells isolated and cultured from the patient’s urine, offering a painless and convenient collection method. This approach is expected to be especially effective for kidney disorders, as these urine-derived stem cells secrete Klotho, a kidney-specific therapeutic factor, which has demonstrated the ability to suppress renal fibrosis and promote the regeneration of damaged kidney tissue in preclinical studies.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}